NIH-funded research R01 grant

Using genetic scores to better predict how weight loss changes metabolic risk

Official title: Using polygenic scores to improve the prediction of weight loss-associated changes in metabolic risk

Funded at Massachusetts General Hospital · NIH-11341635 · Data updated 2026-11-12

A study to see if genetic information can help predict who will have bigger health benefits from weight loss in adults with type 2 diabetes or related metabolic issues.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMassachusetts General Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startJuly 8, 2026
Project endApril 30, 2031
Funding year2026
Award (this year)$842,732
NIH project number1R01DK147322-01
Project IDNIH-11341635 on NIH RePORTER

Who could benefit from this research

Could help

Adults with obesity and metabolic risk factors who may benefit from weight loss interventions could participate.

Less likely to help

Individuals unlikely to experience metabolic improvements from weight loss or who do not provide relevant genetic or health data may see limited benefit.

What this research studies

This project looks at how people respond differently to weight loss by using pathway-specific polygenic scores, which summarize genetic influences on biology. Researchers will analyze large health datasets to find interactions between genetic scores and body weight changes that affect metabolic risk factors like glucose and lipids. They will build a catalog of these interactions and test them across multiple biobanks to understand the biology behind personalized weight-loss responses. The aim is to create more powerful predictors of who benefits most from weight loss interventions, guiding future clinical decisions.

Why it matters

Potential benefit: If successful, the study could lead to personalized weight-loss strategies that maximize metabolic health benefits for individuals.

How similar studies have gone: Prior studies show genetics can influence metabolic responses, but this project expands to pathway-specific scores and large-scale replication, which is relatively novel but builds on existing findings.

Where this research is happening

  • Massachusetts General Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Westerman, Kenneth E — Massachusetts General Hospital
  • Study coordinator: Westerman, Kenneth E

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.